WuXi AppTec and Schr?dinger?unveiled?Faxian Therapeutics, a joint venture aimed at accelerating drug discovery. The new company will use Schr?dinger’s computational drug
Tissue-engineered heart valves are an attractive treatment for heart valve disease, but they tend to change shape and stop working after only a few months.